Global Oncology Biosimilars Market Research Report 2023

Global Oncology Biosimilars Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Biosimilars Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibody
1.2.3 Hematopoietic Agents
1.2.4 G-CSF
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncology Biosimilars Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Biosimilars Market Perspective (2018-2029)
2.2 Oncology Biosimilars Growth Trends by Region
2.2.1 Global Oncology Biosimilars Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oncology Biosimilars Historic Market Size by Region (2018-2023)
2.2.3 Oncology Biosimilars Forecasted Market Size by Region (2024-2029)
2.3 Oncology Biosimilars Market Dynamics
2.3.1 Oncology Biosimilars Industry Trends
2.3.2 Oncology Biosimilars Market Drivers
2.3.3 Oncology Biosimilars Market Challenges
2.3.4 Oncology Biosimilars Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Biosimilars Players by Revenue
3.1.1 Global Top Oncology Biosimilars Players by Revenue (2018-2023)
3.1.2 Global Oncology Biosimilars Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Biosimilars Revenue
3.4 Global Oncology Biosimilars Market Concentration Ratio
3.4.1 Global Oncology Biosimilars Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Biosimilars Revenue in 2022
3.5 Oncology Biosimilars Key Players Head office and Area Served
3.6 Key Players Oncology Biosimilars Product Solution and Service
3.7 Date of Enter into Oncology Biosimilars Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Biosimilars Breakdown Data by Type
4.1 Global Oncology Biosimilars Historic Market Size by Type (2018-2023)
4.2 Global Oncology Biosimilars Forecasted Market Size by Type (2024-2029)
5 Oncology Biosimilars Breakdown Data by Application
5.1 Global Oncology Biosimilars Historic Market Size by Application (2018-2023)
5.2 Global Oncology Biosimilars Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oncology Biosimilars Market Size (2018-2029)
6.2 North America Oncology Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oncology Biosimilars Market Size by Country (2018-2023)
6.4 North America Oncology Biosimilars Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Biosimilars Market Size (2018-2029)
7.2 Europe Oncology Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oncology Biosimilars Market Size by Country (2018-2023)
7.4 Europe Oncology Biosimilars Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Biosimilars Market Size (2018-2029)
8.2 Asia-Pacific Oncology Biosimilars Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oncology Biosimilars Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncology Biosimilars Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Biosimilars Market Size (2018-2029)
9.2 Latin America Oncology Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oncology Biosimilars Market Size by Country (2018-2023)
9.4 Latin America Oncology Biosimilars Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Biosimilars Market Size (2018-2029)
10.2 Middle East & Africa Oncology Biosimilars Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oncology Biosimilars Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncology Biosimilars Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Celltrion
11.1.1 Celltrion Company Detail
11.1.2 Celltrion Business Overview
11.1.3 Celltrion Oncology Biosimilars Introduction
11.1.4 Celltrion Revenue in Oncology Biosimilars Business (2018-2023)
11.1.5 Celltrion Recent Development
11.2 Biocon
11.2.1 Biocon Company Detail
11.2.2 Biocon Business Overview
11.2.3 Biocon Oncology Biosimilars Introduction
11.2.4 Biocon Revenue in Oncology Biosimilars Business (2018-2023)
11.2.5 Biocon Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Detail
11.3.2 Dr. Reddy's Laboratories Business Overview
11.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Introduction
11.3.4 Dr. Reddy's Laboratories Revenue in Oncology Biosimilars Business (2018-2023)
11.3.5 Dr. Reddy's Laboratories Recent Development
11.4 STADA Arzneimittel AG
11.4.1 STADA Arzneimittel AG Company Detail
11.4.2 STADA Arzneimittel AG Business Overview
11.4.3 STADA Arzneimittel AG Oncology Biosimilars Introduction
11.4.4 STADA Arzneimittel AG Revenue in Oncology Biosimilars Business (2018-2023)
11.4.5 STADA Arzneimittel AG Recent Development
11.5 Intas Pharmaceuticals
11.5.1 Intas Pharmaceuticals Company Detail
11.5.2 Intas Pharmaceuticals Business Overview
11.5.3 Intas Pharmaceuticals Oncology Biosimilars Introduction
11.5.4 Intas Pharmaceuticals Revenue in Oncology Biosimilars Business (2018-2023)
11.5.5 Intas Pharmaceuticals Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Oncology Biosimilars Introduction
11.6.4 Pfizer Revenue in Oncology Biosimilars Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Sandoz International
11.7.1 Sandoz International Company Detail
11.7.2 Sandoz International Business Overview
11.7.3 Sandoz International Oncology Biosimilars Introduction
11.7.4 Sandoz International Revenue in Oncology Biosimilars Business (2018-2023)
11.7.5 Sandoz International Recent Development
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Teva Pharmaceutical Industries Ltd Company Detail
11.8.2 Teva Pharmaceutical Industries Ltd Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Introduction
11.8.4 Teva Pharmaceutical Industries Ltd Revenue in Oncology Biosimilars Business (2018-2023)
11.8.5 Teva Pharmaceutical Industries Ltd Recent Development
11.9 Apotex
11.9.1 Apotex Company Detail
11.9.2 Apotex Business Overview
11.9.3 Apotex Oncology Biosimilars Introduction
11.9.4 Apotex Revenue in Oncology Biosimilars Business (2018-2023)
11.9.5 Apotex Recent Development
11.10 BIOCAD
11.10.1 BIOCAD Company Detail
11.10.2 BIOCAD Business Overview
11.10.3 BIOCAD Oncology Biosimilars Introduction
11.10.4 BIOCAD Revenue in Oncology Biosimilars Business (2018-2023)
11.10.5 BIOCAD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Oncology Biosimilars Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Hematopoietic Agents
Table 4. Key Players of G-CSF
Table 5. Key Players of Others
Table 6. Global Oncology Biosimilars Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oncology Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Oncology Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Oncology Biosimilars Market Share by Region (2018-2023)
Table 10. Global Oncology Biosimilars Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Oncology Biosimilars Market Share by Region (2024-2029)
Table 12. Oncology Biosimilars Market Trends
Table 13. Oncology Biosimilars Market Drivers
Table 14. Oncology Biosimilars Market Challenges
Table 15. Oncology Biosimilars Market Restraints
Table 16. Global Oncology Biosimilars Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Oncology Biosimilars Market Share by Players (2018-2023)
Table 18. Global Top Oncology Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biosimilars as of 2022)
Table 19. Ranking of Global Top Oncology Biosimilars Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Oncology Biosimilars Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Oncology Biosimilars Product Solution and Service
Table 23. Date of Enter into Oncology Biosimilars Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oncology Biosimilars Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Oncology Biosimilars Revenue Market Share by Type (2018-2023)
Table 27. Global Oncology Biosimilars Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Oncology Biosimilars Revenue Market Share by Type (2024-2029)
Table 29. Global Oncology Biosimilars Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Oncology Biosimilars Revenue Market Share by Application (2018-2023)
Table 31. Global Oncology Biosimilars Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Oncology Biosimilars Revenue Market Share by Application (2024-2029)
Table 33. North America Oncology Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Oncology Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Oncology Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Oncology Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Oncology Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Oncology Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Oncology Biosimilars Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Oncology Biosimilars Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Oncology Biosimilars Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Oncology Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Oncology Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oncology Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oncology Biosimilars Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Oncology Biosimilars Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Oncology Biosimilars Market Size by Country (2024-2029) & (US$ Million)
Table 48. Celltrion Company Detail
Table 49. Celltrion Business Overview
Table 50. Celltrion Oncology Biosimilars Product
Table 51. Celltrion Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 52. Celltrion Recent Development
Table 53. Biocon Company Detail
Table 54. Biocon Business Overview
Table 55. Biocon Oncology Biosimilars Product
Table 56. Biocon Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 57. Biocon Recent Development
Table 58. Dr. Reddy's Laboratories Company Detail
Table 59. Dr. Reddy's Laboratories Business Overview
Table 60. Dr. Reddy's Laboratories Oncology Biosimilars Product
Table 61. Dr. Reddy's Laboratories Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 62. Dr. Reddy's Laboratories Recent Development
Table 63. STADA Arzneimittel AG Company Detail
Table 64. STADA Arzneimittel AG Business Overview
Table 65. STADA Arzneimittel AG Oncology Biosimilars Product
Table 66. STADA Arzneimittel AG Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 67. STADA Arzneimittel AG Recent Development
Table 68. Intas Pharmaceuticals Company Detail
Table 69. Intas Pharmaceuticals Business Overview
Table 70. Intas Pharmaceuticals Oncology Biosimilars Product
Table 71. Intas Pharmaceuticals Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 72. Intas Pharmaceuticals Recent Development
Table 73. Pfizer Company Detail
Table 74. Pfizer Business Overview
Table 75. Pfizer Oncology Biosimilars Product
Table 76. Pfizer Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Sandoz International Company Detail
Table 79. Sandoz International Business Overview
Table 80. Sandoz International Oncology Biosimilars Product
Table 81. Sandoz International Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 82. Sandoz International Recent Development
Table 83. Teva Pharmaceutical Industries Ltd Company Detail
Table 84. Teva Pharmaceutical Industries Ltd Business Overview
Table 85. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product
Table 86. Teva Pharmaceutical Industries Ltd Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 87. Teva Pharmaceutical Industries Ltd Recent Development
Table 88. Apotex Company Detail
Table 89. Apotex Business Overview
Table 90. Apotex Oncology Biosimilars Product
Table 91. Apotex Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 92. Apotex Recent Development
Table 93. BIOCAD Company Detail
Table 94. BIOCAD Business Overview
Table 95. BIOCAD Oncology Biosimilars Product
Table 96. BIOCAD Revenue in Oncology Biosimilars Business (2018-2023) & (US$ Million)
Table 97. BIOCAD Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Biosimilars Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Oncology Biosimilars Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibody Features
Figure 4. Hematopoietic Agents Features
Figure 5. G-CSF Features
Figure 6. Others Features
Figure 7. Global Oncology Biosimilars Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Oncology Biosimilars Market Share by Application: 2022 VS 2029
Figure 9. Retail Pharmacies Case Studies
Figure 10. Hospital Pharmacy Case Studies
Figure 11. Online Pharmacy Case Studies
Figure 12. Oncology Biosimilars Report Years Considered
Figure 13. Global Oncology Biosimilars Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oncology Biosimilars Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oncology Biosimilars Market Share by Region: 2022 VS 2029
Figure 16. Global Oncology Biosimilars Market Share by Players in 2022
Figure 17. Global Top Oncology Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biosimilars as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oncology Biosimilars Revenue in 2022
Figure 19. North America Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oncology Biosimilars Market Share by Country (2018-2029)
Figure 21. United States Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oncology Biosimilars Market Share by Country (2018-2029)
Figure 25. Germany Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oncology Biosimilars Market Share by Region (2018-2029)
Figure 33. China Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oncology Biosimilars Market Share by Country (2018-2029)
Figure 41. Mexico Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oncology Biosimilars Market Share by Country (2018-2029)
Figure 45. Turkey Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Oncology Biosimilars Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Celltrion Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 48. Biocon Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 49. Dr. Reddy's Laboratories Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 50. STADA Arzneimittel AG Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 51. Intas Pharmaceuticals Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 52. Pfizer Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 53. Sandoz International Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 54. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 55. Apotex Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 56. BIOCAD Revenue Growth Rate in Oncology Biosimilars Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

2023-2031 Report on Global Biosimilar Drug Market by Player, Region, Type, Application and Sales Channel

Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 98

This report studies the Biosimilar Drug market, covering market size for segment by type (Injection, Tablets, etc.), by application (Ankylosing Spondylitis, Tumor, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biosimilar Drug fro......

2023-2031 Report on Global Biosimilar Monoclonal Antibodies Market by Player, Region, Type, Application and Sales Channel

Published: 27-Feb-2023        Price: US 2500 Onwards        Pages: 87

This report studies the Biosimilar Monoclonal Antibodies market, covering market size for segment by type (Infliximab, Rituximab, etc.), by application (Oncology, Autoimmune Disease, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz), Dr Reddy's, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global m......

Global Oncology Biosimilars Market Research Report 2023

Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 85

Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry......

Global Biosimilars Market Research Report 2023

Published: 23-Jan-2023        Price: US 2900 Onwards        Pages: 113

A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.......

Global Biosimilar Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends

Published: 17-Jan-2023        Price: US 3450 Onwards        Pages: 117

Biosimilar therapy is defined as a therapy that is highly similar to approved biopharmaceuticals. They are made by converting biopharmaceuticals made from living cells in the laboratory into large-scale production molecules. This is quite different from the general treatment method, which is identical to the reference small molecule drug. The reason behind this is that it is impossible to make a copy of the same biologic drug. The report focuses on the Biosimilar Drug market size,......

Global Biologics and Biosimilars Market Research Report 2023

Published: 03-Jan-2023        Price: US 2900 Onwards        Pages: 103

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufact......

Global Biologics and Biosimilars Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Published: 03-Jan-2023        Price: US 3480 Onwards        Pages: 118

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactu......

Global Biologics and Biosimilars Sales Market Report 2023

Published: 02-Jan-2023        Price: US 4000 Onwards        Pages: 136

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufact......

Global Adalimumab Biosimilar Market Research Report 2022 - Market Size, Current Insights and Development Trends

Published: 29-Dec-2022        Price: US 3450 Onwards        Pages: 110

Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies. The report focuses on the Adalimumab B......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs